{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:34:11Z","timestamp":1774251251086,"version":"3.50.1"},"reference-count":39,"publisher":"Pleiades Publishing Ltd","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Her. Russ. Acad. Sci."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1134\/s1019331622040025","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T16:05:31Z","timestamp":1662480331000},"page":"404-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["COVID-19: Opportunities to Improve Prognosis"],"prefix":"10.1134","volume":"92","author":[{"given":"S. N.","family":"Avdeev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"7376_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","volume":"180","author":"G. Grasselli","year":"2020","unstructured":"G. Grasselli, M. Greco, A. Zanella, et al., \u201cRisk factors associated with mortality among patients with COVID-19 in Intensive Care Units in Lombardy, Italy,\u201d JAMA Intern. Med. 180 (10), 1345\u20131355 (2020). https:\/\/doi.org\/10.1001\/jamainternmed.2020.3539","journal-title":"JAMA Intern. Med."},{"key":"7376_CR2","doi-asserted-by":"crossref","unstructured":"S. N. Avdeev, \u201cNoninvasive lung ventilation in acute respiratory failure: From clinical guidelines to real clinical practice,\u201d Pul\u2019monologiya, No. 1, 32\u201335 (2018).","DOI":"10.18093\/0869-0189-2018-28-1-32-35"},{"key":"7376_CR3","unstructured":"NHS. Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 (confirmed or suspected), April 6, 2020, Version 3. https:\/\/amhp.org.uk\/app\/uploads\/2020\/03\/Guidance- Respiratory-Support.pdf"},{"key":"7376_CR4","doi-asserted-by":"crossref","unstructured":"M. Vitacca, S. Nava, P. Santus, and S. Harari, \u201cEarly consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: From ward to trenches,\u201d Eur. Respir. J. 55, 2000632 (2020).","DOI":"10.1183\/13993003.00632-2020"},{"key":"7376_CR5","doi-asserted-by":"crossref","unstructured":"S. N. Avdeev, N. A. Tsareva, Z. M. Merzhoeva, et al., \u201cPractical recommendations for oxygen therapy and respiratory support for patients with COVID-19 in the preresuscitation stage,\u201d Pul\u2019monologiya, No. 2, 151\u2013163 (2020).","DOI":"10.18093\/0869-0189-2020-30-2-151-163"},{"key":"7376_CR6","doi-asserted-by":"crossref","unstructured":"E. L\u2019Her, N. Deye, F. Lellouche, et al., \u201cPhysiologic effects of noninvasive ventilation during acute lung injury,\u201d Am. J. Respir. Crit. Care Med, No. 9, 1112\u20131118 (2005).","DOI":"10.1164\/rccm.200402-226OC"},{"key":"7376_CR7","doi-asserted-by":"crossref","unstructured":"S. N. Avdeev, \u201cNoninvasive lung ventilation in patients with chronic obstructive pulmonary disease in hospital and at home,\u201d Pul\u2019monologiya, No. 2, 232\u2013249 (2017).","DOI":"10.18093\/0869-0189-2017-27-2-232-249"},{"key":"7376_CR8","unstructured":"S. N. Avdeev, A. V. Tret\u2019iakov, R. A. Grigor\u2019iants, et al., \u201cStudy of the use of noninvasive ventilation of the lungs in acute respiratory insufficiency due to exacerbation of chronic obstructive pulmonary disease,\u201d Anesteziol. Reanimatol., No. 3, 45\u201351 (1998)."},{"key":"7376_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2020.9524","volume":"324","author":"B. L. Ferreyro","year":"2020","unstructured":"B. L. Ferreyro, F. Angriman, L. Munshi, et al., \u201cAssociation of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure. A systematic review and meta-analysis,\u201d JAMA 324 (1), 57\u201367 (2020).","journal-title":"JAMA"},{"key":"7376_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ajem.2020.09.075","volume":"39","author":"S. Avdeev","year":"2021","unstructured":"S. Avdeev, A. Yaroshetskiy, N. Tsareva, et al., \u201cNoninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19,\u201d Amer. J. Emerg. Med. 39, 154\u2013157 (2021). https:\/\/doi.org\/10.1016\/j.ajem.2020.09.075","journal-title":"Amer. J. Emerg. Med."},{"key":"7376_CR11","doi-asserted-by":"crossref","unstructured":"S. N. Avdeev, \u201cNoninvasive ventilation of the lungs with a new coronavirus infection COVID-19,\u201d Pul\u2019monologiya, No. 5, 679\u2013687 (2020).","DOI":"10.18093\/0869-0189-2020-30-5-679-687"},{"key":"7376_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2147\/CLEP.S278709","volume":"12","author":"A. Potalivo","year":"2020","unstructured":"A. Potalivo, J. Montomoli, F. Facondini, et al., \u201cSixty-day mortality among 520 Italian hospitalized COVID-19 patients according to the adopted ventilatory strategy in the context of an integrated multidisciplinary clinical organization: A population-based cohort study,\u201d Clin. Epidemiol. 12, 1421\u20131431 (2020).","journal-title":"Clin. Epidemiol."},{"key":"7376_CR13","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/jama.2021.4682","volume":"325","author":"D. L. Grieco","year":"2021","unstructured":"D. L. Grieco, L. S. Menga, M. Cesarano, et al., \u201cEffect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: The HENIVOT randomized clinical trial,\u201d JAMA 325 (17),1731\u20131743 (2021).","journal-title":"JAMA"},{"key":"7376_CR14","doi-asserted-by":"publisher","unstructured":"G. D. Perkins, C. Ji, B. A. Connolly, et al., \u201cAn adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19,\u201d MedRxiv, 2022. https:\/\/doi.org\/10.1101\/2021.08.02.21261379","DOI":"10.1101\/2021.08.02.21261379"},{"key":"7376_CR15","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jcrc.2015.07.008","volume":"30","author":"V. Scaravilli","year":"2015","unstructured":"V. Scaravilli, G. Grasselli, L. Castagna, et al., \u201cProne positioning improves oxygenation in spontaneously breathing nonintubated patients with hypoxemic acute respiratory failure: a retrospective study,\u201d J. Crit. Care 30 (6), 1390\u20131394 (2015).","journal-title":"J. Crit. Care"},{"key":"7376_CR16","doi-asserted-by":"crossref","unstructured":"J. S. Alqahtani, R. G. Mendes, A. Aldhahir, et al., \u201cGlobal current practices of ventilatory support management in COVID-19 patients: An international survey,\u201d J. Multidiscip. Healthc., No. 13, 1635\u20131648 (2020).","DOI":"10.2147\/JMDH.S279031"},{"key":"7376_CR17","doi-asserted-by":"crossref","unstructured":"O. R. Perez-Nieto, D. Escarraman-Martinez, M. A. Guerrero-Gutierrez, et al., \u201cAwake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study,\u201d Eur. Respir. J. 59 (2), 2100265 (2022).","DOI":"10.1183\/13993003.00265-2021"},{"key":"7376_CR18","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S2213-2600(21)00356-8","volume":"9","author":"S. Ehrmann","year":"2021","unstructured":"S. Ehrmann, J. Li, M. Ibarra-Estrada, Y. Perez, et al., \u201cAwake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial,\u201d Lancet Respir. Med. 9 (12), 1387\u20131395 (2021).","journal-title":"Lancet Respir. Med."},{"key":"7376_CR19","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/acem.14160","volume":"27","author":"E. M. H. Padrao","year":"2020","unstructured":"E. M. H. Padrao, F. S. Valente, B. A. M. P. Besen, et al., \u201cAwake prone positioning in COVID-19 hypoxemic respiratory failure: Exploratory findings in a single-center retrospective cohort study,\u201d Acad. Emerg. Med. 27 (12), 1249\u20131259 (2020).","journal-title":"Acad. Emerg. Med."},{"key":"7376_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-021-03881-2","volume":"26","author":"M. Esperatti","year":"2022","unstructured":"M. Esperatti, M. Busico, N. A. Fuentes, et al., \u201cImpact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: A\u00a0multicenter cohort study,\u201d Crit. Care. 26 (1), 16 (2022).","journal-title":"Crit. Care."},{"key":"7376_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13054-021-03472-1","volume":"25","author":"S. N. Avdeev","year":"2021","unstructured":"S. N. Avdeev, G. V. Nekludova, N. V. Trushenko, et al., \u201cLung ultrasound can predict response to the prone position in awake non-intubated patients with COVID\u201119 associated acute respiratory distress syndrome,\u201d Crit. Care 25 (1), 35 (2021).","journal-title":"Crit. Care"},{"key":"7376_CR22","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"J. H. Beigel","year":"2020","unstructured":"J. H. Beigel, K. M. Tomashek, L. E. Dodd, et al., \u201cRemdesivir for the treatment of Covid-19: Final report,\u201d New Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"New Engl. J. Med."},{"key":"7376_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2023184","volume":"384","author":"WHO Solidarity Trial Consortium","year":"2021","unstructured":"WHO Solidarity Trial Consortium. H. Pan, R. Peto, A.\u00a0M. Henao-Restrepo, et al., \u201cRepurposed antiviral drugs for Covid-19: Interim WHO Solidarity Trial results,\u201d N. Engl. J. Med. 384 (6), 497\u2013511 (2021).","journal-title":"N. Engl. J. Med."},{"key":"7376_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group. P. Horby, W. S. Lim, J. R. Emberson, et al., \u201cDexamethasone in hospitalized patients with Covid-19,\u201d New Engl. J. Med. 384 (8), 693\u2013704 (2021).","journal-title":"New Engl. J. Med."},{"key":"7376_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group, \u201cTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial,\u201d Lancet 397 (10285), 1637\u20131645 (2021).","journal-title":"Lancet"},{"key":"7376_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa2031994","volume":"384","author":"A. C. Kalil","year":"2021","unstructured":"A. C. Kalil, T. F. Patterson, A. K. Mehta, et al., \u201cBaricitinib plus remdesivir for hospitalized adults with Covid-19,\u201d New Engl. J. Med. 384 (9), 795\u2013807 (2021).","journal-title":"New Engl. J. Med."},{"key":"7376_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1056\/NEJMoa2105911","volume":"385","author":"ATTACC Investigators","year":"2021","unstructured":"ATTACC Investigators; ACTIV-4a Investigators; REMAP-CAP Investigators. P. R. Lawler, E. C. Goligher, J. S. Berger, et al., \u201cTherapeutic anticoagulation with heparin in noncritically ill patients with Covid-19,\u201d New Engl. J. Med. 385 (9), 790\u2013802 (2021).","journal-title":"New Engl. J. Med."},{"key":"7376_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00408-021-00465-3","volume":"199","author":"M. Cazzola","year":"2021","unstructured":"M. Cazzola, P. Rogliani, S. S. Salvi, et al., \u201cUse of thiols in the treatment of COVID-19: Current evidence,\u201d Lung. 199 (4), 335\u2013343 (2021).","journal-title":"Lung."},{"key":"7376_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/23744235.2021.1945675","volume":"53","author":"S. F. Assimakopoulos","year":"2021","unstructured":"S. F. Assimakopoulos, D. Aretha, D. Komninos, et al., \u201cN-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: A two-center retrospective cohort study,\u201d Infect. Dis. (London) 53 (11), 847\u2013854 (2021).","journal-title":"Infect. Dis. (London)"},{"key":"7376_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jinf.2021.07.003","volume":"84","author":"S. N. Avdeev","year":"2022","unstructured":"S. N. Avdeev, V. V. Gaynitdinova, Z. M. Merzhoeva, Z.\u00a0G. Berikkhanov, \u201cN-acetylcysteine for the treatment of COVID-19 among hospitalized patients,\u201d J.\u00a0Infect. 84 (1), 94\u2013118 (2022).","journal-title":"J.\u00a0Infect."},{"key":"7376_CR31","doi-asserted-by":"crossref","unstructured":"V. V. Gainitdinova, S. N. Avdeev, Z. M. Merzhoeva, et\u00a0al., \u201cExperience in the use of N-acetylcysteine in the complex treatment of moderate COVID-associated pneumonia,\u201d Pul\u2019monologiya, No. 1, 21\u201329 (2021).","DOI":"10.1183\/13993003.congress-2021.PA3669"},{"key":"7376_CR32","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1093\/cid\/ciaa1443","volume":"72","author":"J. C. G. de Alencar","year":"2021","unstructured":"J. C. G. de Alencar, C. L. Moreira, A. D. Muller, et al., \u201cDouble-blind randomized placebo-controlled with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by coronavirus disease 2019 (COVID-19),\u201d Clin. Infect. Dis. 72 (11), e736\u2013741 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"7376_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1753466620951043","volume":"14","author":"S. Busani","year":"2020","unstructured":"S. Busani, L. Dall\u2019Ara, R. Tonelli, et al., \u201cSurfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia,\u201d Ther. Adv. Respir. Dis. 14, 1\u20136 (2020).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"7376_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12931-020-01603-w","volume":"22","author":"S. Piva","year":"2021","unstructured":"S. Piva, R. M. DiBlasi, A. E. Slee, et al., \u201cSurfactant therapy for COVID\u201119 related ARDS: A retrospective case-control pilot study,\u201d Respir. Res. 22, 20 (2021). https:\/\/doi.org\/10.1186\/s12931-020-01603-w","journal-title":"Respir. Res."},{"key":"7376_CR35","doi-asserted-by":"publisher","unstructured":"A. E. Bautin, S. N. Avdeev, A. A. Seiliev, et al., \u201cSurfactant inhalation therapy in the integrated treatment of severe COVID-19 pneumonia,\u201d Tuberkulez Bolezni Legkikh, No. 9, 6\u201312 (2020). https:\/\/doi.org\/10.21292\/2075-1230-2020-98-9-6-12","DOI":"10.21292\/2075-1230-2020-98-9-6-12"},{"key":"7376_CR36","doi-asserted-by":"crossref","unstructured":"S. N. Avdeev, N. V. Trushenko, S. Y. Chikina, et al., \u201cBeneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome,\u201d Respir. Med. 185, 106489 (2021).","DOI":"10.1016\/j.rmed.2021.106489"},{"key":"7376_CR37","doi-asserted-by":"crossref","unstructured":"J. R. DeGrado, P. M. Szumita, B. R. Schuler, et al., \u201cEvaluation of the efficacy and safety of inhaled epoprostenol and inhaled nitric oxide for refractory hypoxemia in patients with coronavirus disease 2019,\u201d Crit. Care Explor. 2 (10), e0259 (2020).","DOI":"10.1097\/CCE.0000000000000259"},{"key":"7376_CR38","doi-asserted-by":"crossref","unstructured":"J. Li, J. B. Fink, A. E. Augustynovich, S. Mirza, et al., \u201cEffects of inhaled epoprostenol and prone positioning in intubated coronavirus disease 2019 patients with refractory hypoxemia,\u201d Crit. Care Explor. 2 (12), e0307 (2020).","DOI":"10.1097\/CCE.0000000000000307"},{"key":"7376_CR39","doi-asserted-by":"crossref","unstructured":"N. A. Tsareva, S. N. Avdeev, D. Kosanovic, et al., \u201cInhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome,\u201d Crit. Care 25 (1), Article no. 258 (2021).","DOI":"10.1186\/s13054-021-03690-7"}],"container-title":["Herald of the Russian Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1019331622040025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1019331622040025","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1019331622040025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:39:58Z","timestamp":1774247998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1019331622040025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7376"],"URL":"https:\/\/doi.org\/10.1134\/s1019331622040025","relation":{},"ISSN":["1019-3316","1555-6492"],"issn-type":[{"value":"1019-3316","type":"print"},{"value":"1555-6492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"1 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares that he has no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}